These results suggest that YST improved glucose intolerance and showed anti-obesity effects by regulating the adipocyte-derived hormones leptin and adiponectin at the serum and mRNA levels. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.